# The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial

> **NCT03402048** · PHASE3 · UNKNOWN · sponsor: **University of Turin, Italy** · enrollment: 567 (estimated)

## Conditions studied

- Stage IV, NSCLC
- Lung Neoplasms
- Bronchial Neoplasms
- Carcinoma, Bronchogenic
- Lung Diseases
- Neoplasms
- Respiratory Tract Diseases
- Respiratory Tract Neoplasms
- Thoracic Neoplasms

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** Gemcitabine
- **DRUG:** Pemetrexed
- **DRUG:** Docetaxel
- **DRUG:** Vinorelbine

## Key facts

- **NCT ID:** NCT03402048
- **Lead sponsor:** University of Turin, Italy
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-07
- **Primary completion:** 2020-12
- **Final completion:** 2021-05
- **Target enrollment:** 567 (ESTIMATED)
- **Last updated:** 2020-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03402048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03402048, "The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03402048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*